Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib

  • H. A.F. Stessman
  • , A. Mansoor
  • , F. Zhan
  • , S. Janz
  • , M. A. Linden
  • , L. B. Baughn
  • , B. Van Ness

Research output: Contribution to journalArticlepeer-review

48 Scopus citations
Original languageEnglish (US)
Pages (from-to)2075-2077
Number of pages3
JournalLeukemia
Volume27
Issue number10
DOIs
StatePublished - Oct 2013

Bibliographical note

Funding Information:
BVN receives research support from Millennium Pharmaceuticals Inc., Cambridge, MA. The other authors declare no conflict of interest.

Cite this